Development and characterization of chronotherapeutic tablets of sacubitril-valsartan supramolecular complex using hupu gum and lannea gum by compression coating
{"title":"Development and characterization of chronotherapeutic tablets of sacubitril-valsartan supramolecular complex using hupu gum and lannea gum by compression coating","authors":"Rajeswari Aleti, K. V. R. Murthy","doi":"10.7324/japs.2023.120714","DOIUrl":null,"url":null,"abstract":"Sacubitril-valsartan supramolecular complex (SVSC), a first-in-class Angiotensin Receptor Neprilysin Inhibitor has been approved as safe and effective treatment for Heart Failure with Reduced Ejection Fraction and reduce the risk of cardiovascular death and re-hospitalization in patients with striking rise in blood pressure during early morning hours. As the cardiovascular events are well associated with circadian rhythms, chronotherapeutic drug delivery of SVSC at bedtime (around 10 p.m.) may be a potential approach. Aim and objective of present investigation is to develop chronotherapeutic drug delivery system of SVSC using natural gums by compression coating technique that is appropriate in achieving predetermined lag time of 5-6 hours followed by maximum drug release within 1 hour to attain the required C max when the disease condition is at peak. Initially the core tablets were optimized which completely released the drug in 25 minutes. The optimized core tablets were subjected to compression coating with different ratios of hupu gum, lannea gum and channeling agent for preparation of chronotherapeutic tablets. The optimized compression coated tablets complied with the official and other requirements of tablets. Differential scanning calorimetry and Fourier transformed infrared spectroscopy studies confirmed the drug and excipient compatibility. Among all formulations, Compression coated Tablets CCT3 met all the objectives of present investigation and hence, selected as optimized compression coated tablet suitable for chronotherapeutic drug delivery of SVSC in patients with heart failure.","PeriodicalId":15126,"journal":{"name":"journal of applied pharmaceutical science","volume":"140 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"journal of applied pharmaceutical science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7324/japs.2023.120714","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Sacubitril-valsartan supramolecular complex (SVSC), a first-in-class Angiotensin Receptor Neprilysin Inhibitor has been approved as safe and effective treatment for Heart Failure with Reduced Ejection Fraction and reduce the risk of cardiovascular death and re-hospitalization in patients with striking rise in blood pressure during early morning hours. As the cardiovascular events are well associated with circadian rhythms, chronotherapeutic drug delivery of SVSC at bedtime (around 10 p.m.) may be a potential approach. Aim and objective of present investigation is to develop chronotherapeutic drug delivery system of SVSC using natural gums by compression coating technique that is appropriate in achieving predetermined lag time of 5-6 hours followed by maximum drug release within 1 hour to attain the required C max when the disease condition is at peak. Initially the core tablets were optimized which completely released the drug in 25 minutes. The optimized core tablets were subjected to compression coating with different ratios of hupu gum, lannea gum and channeling agent for preparation of chronotherapeutic tablets. The optimized compression coated tablets complied with the official and other requirements of tablets. Differential scanning calorimetry and Fourier transformed infrared spectroscopy studies confirmed the drug and excipient compatibility. Among all formulations, Compression coated Tablets CCT3 met all the objectives of present investigation and hence, selected as optimized compression coated tablet suitable for chronotherapeutic drug delivery of SVSC in patients with heart failure.
期刊介绍:
Journal of Applied Pharmaceutical Science (JAPS) is a monthly, international, open access, journal dedicated to various disciplines of pharmaceutical and allied sciences. JAPS publishes manuscripts (Original research and review articles Mini-reviews, Short communication) on original work, either experimental or theoretical in the following areas; Pharmaceutics & Biopharmaceutics Novel & Targeted Drug Delivery Nanotechnology & Nanomedicine Pharmaceutical Chemistry Pharmacognosy & Ethnobotany Phytochemistry Pharmacology & Toxicology Pharmaceutical Biotechnology & Microbiology Pharmacy practice & Hospital Pharmacy Pharmacogenomics Pharmacovigilance Natural Product Research Drug Regulatory Affairs Case Study & Full clinical trials Biomaterials & Bioactive polymers Analytical Chemistry Physical Pharmacy.